RxDoctor Payments DataLook up a doctor →

Stuart Schrader, DO

Internal Medicine · Oklahoma City, OKNPI 1336173491

Payments from drug & device makers

$28,546in general payments, 2019–2025

Across 791 payments — averaging $36.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exact Sciences$17K
  • AbbVie$1K
  • Lilly USA, LLC$923
  • AstraZeneca$867
  • Amgen$782
  • Bayer$713
  • plus $7K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Exact Sciences7$16,649
AbbVie(2 entities)65$1,033
Lilly USA, LLC80$923
AstraZeneca36$867
Amgen(2 entities)44$782
Bayer53$713
Novo Nordisk62$625
Pfizer43$527
Teva Pharmaceuticals USA, Inc.25$527
Takeda Pharmaceuticals U.S.A., Inc.23$426
GSK37$425
Supernus Pharmaceuticals, Inc.16$407
Corium, LLC16$291
Ironshore Pharmaceuticals Inc.15$273
Abbott16$269
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC16$237
Boehringer Ingelheim13$203
Merck25$202
Johnson & Johnson13$196
Eisai Inc.12$190
Actelion Pharmaceuticals US, Inc.8$147
Mannkind Corporation9$141
Axsome Therapeutics, Inc.8$139
IBSA Pharma Inc.8$128
Shire North American Group Inc9$128
Organon8$100
Biohaven Pharmaceutical Holding Company Ltd.6$95
Antares Pharma, Inc.5$93
Sanofi-aventis U.S. LLC6$91
Corcept Therapeutics5$88
Novartis5$86
Collegium Pharmaceutical, Inc.5$85
Amarin Pharma, Inc.6$83
Biohaven Pharmaceuticals, Inc.5$82
Harmony Biosciences LLC4$79
Dynavax Technologies Corporation5$74
Sumitomo Pharma America, Inc.3$70
Phathom Pharmaceuticals, Inc.6$57
Paratek Pharmaceuticals, Inc.4$55
Inspire Medical Systems, Inc.3$54
Arbor Pharmaceuticals, Inc.4$54
Noven Therapeutics, LLC4$54
Gilead2$53
Boston Scientific2$52
Nabriva Therapeutics, PLC3$45
Tris Pharma Inc3$44
Nalu Medical, Inc.2$41
Kowa Pharmaceuticals America, Inc.3$40
Jazz Pharmaceuticals Inc.3$38
Ultragenyx Pharmaceutical Inc.2$36
Genentech USA, Inc.2$36
Vertical Pharmaceuticals, LLC2$30
Therapeuticsmd, Inc.2$27
Almatica Pharma LLC2$27
Xeris Pharmaceuticals, Inc.1$24
Hologic Sales And Service, LLC2$23
Melinta Therapeutics, LLC1$22
Tandem Diabetes Care, Inc.1$21
Insulet Corporation1$21
Smith+Nephew1$19

How this compares

$28,546 in reported general payments places this provider in the 95th percentile of 840 internal medicine providers in Oklahoma.

See all internal medicine providers in Oklahoma →

Medicare billing

Part B allowed, 2024
$140,535
Medicare patients
596
Services billed
2,112

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Oklahoma City

See the full list for Oklahoma →

Where these figures come from

Is this you, or does something look wrong? →